IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John S. Baker who wrote (971)	7/23/1998 9:30:00 PM
From: Doug Heuring	Read Replies (1) of 1510

can someone tell me if this is new or old, if its new, could be very good day tomorrow. found it at yahoo thread <- Previous Message 3348 of 3348ÿÿÿÿ Reply ÿÿÿÿÿ From Bloomberg, 7/23/98Country_Doctor Jul 23 1998 9:03PM EDThttp://quote.bloomberg.com/analytics/bquote.cgi?view=bq&version=front.cfg&ticker =IMNR Ever-New Drug Cocktails for Containing AIDS: Drugs' New Era (an excerpt follows:) One of the most promising new HIV treatments comes from Immune Response Corp., a company co-founded by the late Jonas Salk, who developed the polio vaccine and who as far back as 1987 was looking at immunization as a way of fighting AIDS. Immune Response, in a partnership with Agouron Pharmaceuticals Inc., could apply for U.S. approval next year of Remune, its treatment to boost the immune system's response in people infected with HIV. ------------------------------------- We certainly deserve some good press. CD ÿIMNR:ÿ Quote ÿ\|ÿ Profile ÿ\|ÿResearch This Is a Reply to: Msg 3347 by Cyngnes <- Previous Message 3348 of 3348

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next